Drug General Information
Drug ID	D0DP0J
Drug Name	PR-924
Indication	T lymphoblastic lymphoma/leukemia [ICD10:C91-C95]		Phase 1	[1572596]
Structure		Download 2D MOL 3D MOL
Drug Resistance Mutation (DRM)
DRM	DRM Info
References
Ref 1572596	PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.